STAT+: The field is exploding, but microbiome therapeutics still face a wave of challenges 

Even as drug makers are poised to introduce actual medicines to change a person’s microbiome and make them healthier, there’s a lot we don’t know about the billions of organisms that live inside us. We don’t know all their names, let alone everything they’re capable of doing.

In a deep new report, STAT examines what we do know about this field — the science powering this new array of therapies, the companies already charging toward new drug applications, and, critically, the many challenges still to come.

Continue to STAT+ to read the full story…